Date

Title

View

14 Jan 16

SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

14 Jan 16

SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

14 Jan 16

SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

14 Jan 16

SYGNIS AG attends Festival of Genomics in London, UK

View View

13 Jan 16

SYGNIS AG announces Global Launch of SunScript(TM) One Step RT-qPCR Kit

View View

08 Jan 16

SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

24 Dec 15

SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

24 Dec 15

SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

21 Dec 15

SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

17 Dec 15

SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View

17 Dec 15

SYGNIS AG significantly expands its Asian distribution network by signing three additional agreements with PhileKorea and Pharma Tech Korea as well as Axil Scientific for Singapore

View View

17 Dec 15

SYGNIS AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

View View